(Q44193442)

English

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. (English)

1 reference

Europe PubMed Central

30 November 2017

0 references

0 references

bioavailability

1 reference

based on heuristic

inferred from title

author name string

Jaw-Wen Chen

1

1 reference

Europe PubMed Central

30 November 2017

Nai-Wei Hsu

2

1 reference

Europe PubMed Central

30 November 2017

Tao-Cheng Wu

3

1 reference

Europe PubMed Central

30 November 2017

Shing-Jong Lin

4

1 reference

Europe PubMed Central

30 November 2017

Mau-Song Chang

5

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

30 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

30 November 2017

90

1 reference

Europe PubMed Central

30 November 2017

9

1 reference

Europe PubMed Central

30 November 2017

974-982

1 reference

Europe PubMed Central

30 November 2017

Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Pathophysiological dilemma of syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Mechanisms of angina pectoris in syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins

2 references

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of coronary flow reserve after long-term therapy with enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

von Willebrand factor, endothelial cell damage and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Maximal blood flow velocity in severe coronary stenoses measured with a Doppler guidewire. Limitations for the application of the continuity equation in the assessment of stenosis severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Angina pectoris caused by coronary microvascular spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Endogenous nitric oxide synthase inhibitors are responsible for the L -arginine paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Syndrome X and endothelial dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902664-4

7 January 2021

Identifiers

10.1016/S0002-9149(02)02664-4

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44193442&oldid=2108397376"